The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Exploring the impact of naltrexone on the THBS1/eNOS/NO pathway in osteoporotic bile duct-ligated rats
Open accessAbstract
Hepatic osteodystrophy, a prevalent manifestation of metabolic bone disease, can arise in the context of chronic liver disease. The THBS1-eNOS-NO signaling pathway plays a pivotal role in the maturation of osteoclast precursors. This study aimed to investigate the impact of Naltrexone (NTX) on bone loss by examining the THBS1-eNOS-NO signaling pathways in bile duct ligated (BDL) rats. Male Wistar rats were randomly divided into five groups (n = 10 per group): control, sham-operated + normal saline, BDL + normal saline, sham-operated + NTX (10 mg/kg), and BDL + NTX. Parameters related to liver injury were measured at the study's conclusion, and Masson-trichrome staining was employed to evaluate collagen deposition in liver tissue. Bone THBS-1 and endothelial nitric oxide synthase (eNOS) expression levels were measured using real-time PCR, while the level of bone nitric oxide (NO) was assessed through a colorimetric assay. NTX treatment significantly attenuated the BDL-induced increase in circulating levels of liver enzymes and bilirubin. THBS-1 expression levels, elevated after BDL, were significantly suppressed following NTX administration in the BDL + NTX group. Despite no alterations in eNOS expression between groups, the bone NO level, significantly decreased in the BDL group, was significantly reduced by NTX in the BDL + NTX group. This study partly provides insights into the possible molecular mechanisms in BDL-induced osteoporosis and highlights the modulating effect of NTX on these pathways. Further research is needed to establish the impact of NTX on histomorphometric indexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two additional experimental studies indicated a pro-osteogenic effect of naltrexone in a murine model of osteoporosis induced by liver cirrhosis (211, 212).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [211]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, J.-H., Bhang, D. H., Beede, A., Huang, T. L., Stripp, B. R., Bloch, K. D., Wagers, A. J., Tseng, Y.-H., Ryeom, S., & Kim, C. F. (2014) · Cell · doi:10.1016/j.cell.2013.12.039 · Cited by 490 · cited 1×
“By modulating cellular adhesion, migration, and differentiation, THBS-1 engages in various processes such as fibrosis and regulation of angiogenesis 21–23 .”
BackgroundMolecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
Ramos-Tovar, E., & Muriel, P. (2020) · Antioxidants · doi:10.3390/antiox9121279 · Cited by 340 · cited 1×
“Another study proposed that hepatic oxidative stress might trigger the activation of hepatic stellate cells (HSCs), consequently inducing the synthesis and release of collagen 40 .”
BackgroundTanaka, S., Nakamura, K., Takahasi, N., & Suda, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00327.x · Cited by 320 · cited 1×
“The inhibition of the bone resorption activity of osteoclasts remains a high priority for most current osteoporosis therapies 12,13 .”
BackgroundHow the osteoclast degrades bone
Blair, H. C. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199810)20:10<837::aid-bies9>3.0.co;2-d · Cited by 219 · cited 1×
“Osteoclastogenesis, a complex and multistep process, involves the formation of mature OCs responsible for breaking down both the organic and inorganic components of formed bones 9 .”
BackgroundDr. Dodds, R. A., Connor, J. R., James, I. E., Lee Rykaczewski, E., Appelbaum, E., Dul, E., & Gowen, M. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101109 · Cited by 181 · cited 1×
“However, there remains considerable uncertainty regarding the role of proteins sequestered in the osteoid deposited by osteoblasts (OB) in the regulation of osteoclastogenesis 11 .”
BackgroundOsteoclastogenesis, Bone Resorption, and Osteoclast-Based Therapeutics
Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E., & Huang, C. L.-H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.4.599 · Cited by 180 · cited 1×
“The inhibition of the bone resorption activity of osteoclasts remains a high priority for most current osteoporosis therapies 12,13 .”
BackgroundHow the osteoclast degrades bone
Blair, H. C. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199810)20:10<819::aid-bies7>3.0.co;2-n · Cited by 178
Jurk, K., Clemetson, K. J., de Groot, P. G., Brodde, M. F., Steiner, M., Savion, N., Varon, D., Sixma, J. J., Van Aken, H., & Kehrel, B. E. (2003) · The FASEB Journal · doi:10.1096/fj.02-0830fje · Cited by 158 · cited 1×
“By modulating cellular adhesion, migration, and differentiation, THBS-1 engages in various processes such as fibrosis and regulation of angiogenesis 21–23 .”
BackgroundShort, S. M., Derrien, A., Narsimhan, R. P., Lawler, J., Ingber, D. E., & Zetter, B. R. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407060 · Cited by 137 · cited 2×
“It binds to its two cell-associated receptors CD36 and CD47, and by inhibiting endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO) signaling, promotes osteoclast differentiation 22 .”
BackgroundRouillard, S., & Lane, N. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20533 · Cited by 125
Research works printed but not linked: 1
- Mani, Ι & Dourakis, S. Hepatic osteodystrophy: Current views. Arch. Hellenic Med. 33(5), 596–609 (2016).
Cited by
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Endogenous opiates and behavior: 2024
Bodnar, R. J. (2025) · Peptides · doi:10.1016/j.peptides.2025.171422 · Cited by 7
Huang, W., Zhou, C., Wu, R. T., Zhao, K., Wu, J., & Song, D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168139 · Cited by 5
Britton, A., Harinath, G., Morgan, S. L., & Zalzala, S. (2025) · Cureus · doi:10.7759/cureus.77435 · Cited by 1
“Additionally, low-dose naltrexone may influence bone health through multiple pathways, such as modulating immune activity and blunting chronic inflammation to benefit bone signaling and metabolism, or through improvements in bone health associated with opioid receptor antagonism [29-32].”
Mahmoudi, S. S., Farshid, A. A., Tamaddonfard, E., Erfanparast, A., & Imani, M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178932
Metadata
- Authors
- Hosseini-Fard, S. R., Etemad-Moghadam, S., Alaeddini, M., Dehpour, A. R., Emamgholipour, S., & Golestani, A.
- Affiliations
- Tehran University of Medical Sciences (IR)
- Corresponding author
- Emamgholipour, Solaleh
- Golestani, Abolfazl
- Venue
- Scientific Reports
- Published
- 2024-01-02
- Volume
- 14
- Issue
- 1
- Pages
- 48-48
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC10761994
- OpenAlex
- W4390501288
- Semantic Scholar
- 8cbd08dd1edc702b95dd51a3adc28fe7e90e80e3
- Cited by
- 6
- References
- 43
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Tehran University of Medical Sciences and Health Services (54103)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- naltrexone, thrombospondin-1, endothelial nitric oxide synthase, nitric oxide, bile duct ligation, hepatic osteodystrophy, osteoporosis, chronic liver disease, bone loss, liver enzymes, collagen deposition
- MeSH terms
- Saline Solution, Animals, Bile Ducts, Ligation, Liver, Liver Cirrhosis, Male, Naltrexone, Rats, Wistar, Rats, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring the impact of naltrexone on the THBS1/eNOS/NO pathway in osteoporotic bile duct-ligated rats. https://app.cochat.ai/papers/10.1038/s41598-023-50547-w
- The paper
- Hosseini-Fard, S. R., Etemad-Moghadam, S., Alaeddini, M., Dehpour, A. R., Emamgholipour, S., & Golestani, A. (2024). Exploring the impact of naltrexone on the THBS1/eNOS/NO pathway in osteoporotic bile duct-ligated rats. Scientific Reports. https://doi.org/10.1038/s41598-023-50547-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.